Missak Haigentz
7PUBLICATIONS
54CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087).Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao
|Feb 23, 2023
Waiting for Big Changes in Limited-Stage Small-Cell Lung Cancer: For Now, More of the Same.Matthew P Deek, Missak Haigentz, Salma K Jabbour
|Dec 01, 2022
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.Charu Aggarwal, Nabil F Saba, Alain Algazi
|Nov 03, 2019
Targeting the EGFR and Immune Pathways in Squamous Cell Carcinoma of the Head and Neck (SCCHN): Forging a New Alliance.Nabil F Saba, Zhuo Gerogia Chen, Missak Haigentz
|Aug 15, 2018
The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma.Marc Hamoir, Sandra Schmitz, Carlos Suarez
Pageof 2
Frequent Collaborators
2 joint publications
Juan P Rodrigo
1 joint publications
Marc Hamoir
1 joint publications
Primoz Strojan
1 joint publications
Antti A Mäkitie
1 joint publications
Jan B Vermorken
1 joint publications
Charu Aggarwal
1 joint publications
Nabil F Saba
1 joint publications
Alain Algazi
1 joint publications
Ammar Sukari
1 joint publications
Tanguy Y Seiwert
